In Lyme advocate Carl Tuttle’s petition update, he includes the following letter from Dr. Sin Hang Lee, which asks a crucial question:
Why isn’t the CDC using 2-tiered testing for the Coronavirus?
March 1, 2020
Re: Lyme Disease and COVID-19 infection
Dear Attorney Huntley:
I am the Plaintiff-Appellant in the United States Court of Appeals FOR THE FEDERAL CIRCUIT case No. 19-2060-JL. This case is against the Centers for Disease Control and Prevention (CDC) about breach of a contract to continue evaluation of polymerase chain reaction (PCR)/DNA sequencing against the two-tier serology test in the diagnosis of Lyme disease infections for better patient care.
You are the CDC lawyer who is blocking a public hearing in court through a series of legal maneuvers.
This letter requests that you on behalf of the CDC answer an extremely relevant question in view of the current COVID-19 outbreak:
Why is the CDC not using a two-tier serology test for the diagnosis of COVID-19 infection, as for Lyme disease infection?
I think both the Lyme disease patients and potential COVID-19 patients would like to know the answers.
Thank you in advance.
Sin Hang Lee, MD
For the record: the CDC has implemented a Real-time polymerase chain reaction test kit for the coronavirus (DNA direct detection method).
Nearly four decades into the Lyme disease epidemic we are still using antiquated serology because serology cannot be used to gauge treatment failure or success or identify persistent infection keeping the IDSA doctrine intact; “Lyme is hard to catch and easily treated.”
Direct detection methods for Lyme disease must be avoided at all costs.
Today, Tuttle set forth 3 more questions for CDC Attorney Huntley:
1. Why did it take the CDC 35 years to recognize mother-to-fetus transmission of Lyme disease when it was reported back in 1985 per the attached list of twenty six references? https://www.dropbox.com/s/z10em0szgpm8bll/Congenital%20Transmission%20of%20Lyme%202015.doc?dl=0
U.S. health agency acknowledges Lyme disease mother-to-fetus transmission Published: Feb 11, 2020
It should be noted that transmission of Lyme to the new born occurred despite antibiotic treatment.
Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy.
Published 1988 Paul H. Duray, Infectious Diseases
2. Why has the CDC suppressed evidence of persistent infection after extensive antibiotic treatment as identified in the attached 2012 letter addressed to past CDC Director Brenda Fitzgerald, MD?
The 1991 Positive CSF Culture Report identified in that letter (performed by the CDC’s Fort Collins laboratory) should have set off a red flag but was ignored while the focus remained on discrediting the sick and disabled Lyme patient population. The autopsy report shows the destructive nature of Borrelia evident in the liver (nutmeg liver), kidneys, heart, lungs and brain. The patient died after the insurer refused additional IV antibiotic therapy. (Medical execution)
Patient testimony all across America is describing a disease that is destroying lives, ending careers while leaving its victim in financial ruin and yet the disease is classified as a low-risk and non-urgent health threat.
Six of the seven defendants of the Lisa Torrey vs. IDSA racketeering lawsuit were authors of the Lancet article below. It is no secret that the CDC has aligned themselves with these defendants and supplied the financing of the ‘Enterprise” through taxpayer funds under CDC Grant# RO1 CK 000152
NIH Online Reporting Tools
3. Does sovereign immunity protect government health officials involved in acts of atrocity?
Lastly, Regarding testing:
There has been a history of concerted suppression of direct testing for Lyme disease: https://madisonarealymesupportgroup.com/2017/12/13/suppression-of-microscopy-for-lyme-diagnostics-professor-laane/
This article also reveals how Lida Mattman’s Gold Standard Culture Method has disappeared thanks to this concerted suppression: https://madisonarealymesupportgroup.com/2019/04/02/transmission-of-lyme-disease-lida-mattman-phd/
Never forget that the very folks at the table making decisions for patients have their hands in pharmaceutical coffers with patents on testing for Lyme: ConflictReport
Dr. Lee is suing the CDC due to this suppression: https://madisonarealymesupportgroup.com/2018/05/15/news-release-on-57-1-million-lyme-disease-lawsuit-filed-against-cdc/
This recent study shows current 2-tiered testing is inaccurate in more than 70% of cases: https://madisonarealymesupportgroup.com/2020/03/01/study-cdcs-2-tier-lyme-testing-inaccurate-in-more-than-70-of-cases/
I think the public has waited long enough for the answers to these questions.